BioCryst Pharmaceuticals | BCRX - 销售毛利

股票价格

9.56

每天变化

-0.33 -3.34%

每月一次

12.60%

每年

40.18%

Q2 预测

9.30

金融业

USD

USD 514.16M

现金及等价物

USD 335.91M

USD 9.52M

USD 404.35M

USD 196.07M

USD 828.6M

股息收益率

0

USD 260.39M

USD 51.7M

536

EPS每股收益

USD 1.17

股本和储备

USD -119.15M

USD 153.05M

债务利息支出

USD 14.14M

USD -0.13

USD 428.67M

USD 1.98B

USD 245.85M

USD 146.17M

USD 260.39M

普通股股本

USD 213.06M

6.06

USD 248.02M

USD 406.56M

销售和管理费用

USD 95.78M

USD 5.4M

贸易债权人

USD 15.83M

应收帐款人

USD 106.82M

	销售毛利	更改		日
Alnylam Pharmaceuticals	USD 829.31M		219.56M	2025-12
BioCryst Pharmaceuticals	USD 153.05M		4.16M	2025-12
Chugai Pharma	JPY 258.74B		25.81B	2025-12
Daiichi Sankyo	JPY 439.83B		95.05B	2025-12
DBV Technologies	USD 2.77M		33.21M	2025-09
Enanta Pharmaceuticals	-22.29M		23.75M	2024-12
Gilead Sciences	USD 6.31B		106M	2025-12
GlaxoSmithKline	GBP 6.18B		106M	2025-12
Glaxosmithkline	GBP 8.75B		2.92B	2025-09
Incyte	USD 1.39B		118.68M	2025-12
Ionis Pharmaceuticals	USD 195M		40M	2025-12
Karyopharm Therapeutics	USD 32.6M		63.38M	2025-12
Neurocrine Biosciences	USD 787.9M		7M	2025-12
Novavax	USD 125.04M		76.09M	2025-12
PTC Therapeutics	USD 148.38M		39.31M	2025-12
Regeneron Pharmaceuticals	USD 3.3B		67M	2025-12
Roche Holding	CHF 22.09B		10.04B	2025-12
Sarepta Therapeutics	USD 43.55M		204.36M	2025-12
Ultragenyx Pharmaceutical	USD 178M		46.06M	2025-12
Vertex Pharmaceuticals	USD 2.72B		62.4M	2025-12